Prestige BioPharma Limited (프레스티지바이오파마)
KOSPI Stock Code: 950210 | DART Corp Code: 01510489
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
| English name (as registered with DART) | Prestige BioPharma Limited |
|---|---|
| Korean legal name | 프레스티지바이오파마 |
| Alternate names | — |
| Market | KOSPI |
| Stock Code | 950210 |
| DART Corp Code | 01510489 |
| CEO | 박소연 |
| Business Registration No. | 49190 |
| Corporate Registration No. | N/A |
| Established Date | 2015-07-13 |
| Fiscal Month | 06 |
| KSIC Industry Code | 70113 |
| Address (KO) | 21 BIOPOLIS ROAD #04-24 NUCLEOS SINGAPORE (138567) - |
| Homepage | https://www.prestigebiopharma.com/ |
| source_url | https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20250923000316 |
| verified_at | 2026-11-01T02:27:34.708Z |
Annual Financial Summary (KRW)
Fiscal Year: 2025 | Basis: CFS (Consolidated) | Currency: KRW | Filing Source: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20250923000316
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 10,215,103 | KRW 517,114 |
| Operating Income (영업이익) | KRW -48,025,250 | KRW -47,115,233 |
| Net Income (당기순이익) | KRW 2,974,299 | KRW -41,348,110 |
| Total Assets (자산총계) | KRW 549,730,458 | KRW 512,323,973 |
| Total Liabilities (부채총계) | KRW 174,980,222 | KRW 141,245,763 |
| Total Equity (자본총계) | KRW 374,750,236 | KRW 371,078,210 |
Recent DART Filings (Last 90 Days, up to 20)
| Filed Date | Receipt No. | English Title | Korean Title | Filer |
|---|---|---|---|---|
2026-09-29 | 20260929800653 | Foreign Corporation, etc. : Report on Appointment or Dismissal or Change of External Auditor | 유가증권시장상장외국법인외부감사인선임ㆍ해임ㆍ변경신고서 | 프레스티지바이오파마 |
2026-09-29 | 20260929800648 | Outcome of Annual Shareholders' Meeting | 정기주주총회결과 | 프레스티지바이오파마 |
2026-09-29 | 20260929000483 | Report on the Appointment, Dismissal or Early Retirement of Independent Directors | 독립이사의선임ㆍ해임또는중도퇴임에관한신고 | 프레스티지바이오파마 |
2026-09-23 | 20260923000252 | [Corrected description]Annual Report (2026.06) | [기재정정]사업보고서 (2026.06) | 프레스티지바이오파마 |
2026-09-22 | 20260921000435 | Annual Report (2026.06) | 사업보고서 (2026.06) | 프레스티지바이오파마 |
2026-09-21 | 20260921800621 | Submission of Audit Report | 감사보고서제출 | 프레스티지바이오파마 |
2026-09-14 | 20260914800459 | Decision on Calling Shareholders' Meeting | 주주총회소집결의 | 프레스티지바이오파마 |
2026-09-14 | 20260914000213 | Announcement of convocation of general meeting of shareholders | 주주총회소집공고 | 프레스티지바이오파마 |
2026-09-01 | 20260901800109 | Report on Shares Change of Largest Shareholders | 최대주주등소유주식변동신고서 | 프레스티지바이오파마 |
2026-09-01 | 20260901000026 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 고상석 |
2026-09-01 | 20260901000023 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 메이슨파트너스 |
2026-08-25 | 20260825800279 | [Corrected description]Conclusion of Single Sales Contract or Supply Contract | [기재정정]단일판매ㆍ공급계약체결 | 프레스티지바이오파마 |
2026-08-19 | 20260819800177 | Report on Shares Change of Largest Shareholders | 최대주주등소유주식변동신고서 | 프레스티지바이오파마 |
2026-08-19 | 20260819000126 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 메이슨파트너스 |
2026-08-19 | 20260819000125 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 고상석 |
2026-08-14 | 20260814803580 | Changes of 30% or More in Sales or Profits/Losses (15% or More in the Case of Large-sized Corporations) | 매출액또는손익구조30%(대규모법인은15%)이상변경 | 프레스티지바이오파마 |
2026-08-11 | 20260811800081 | Report on Shares Change of Largest Shareholders | 최대주주등소유주식변동신고서 | 프레스티지바이오파마 |
2026-08-11 | 20260811000034 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 박소연 |
2026-08-11 | 20260811000027 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 메이슨파트너스 |
2026-08-04 | 20260804000527 | [Corrected description]Report on status of specific securities, etc. owned by executives and major shareholders | [기재정정]임원ㆍ주요주주특정증권등소유상황보고서 | 박소연 |
Source & Disclaimer
source_url: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20250923000316 | verified_at: 2026-11-01T02:27:34.708Z
Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.